| Serial Number | 98828714 |
| Word Mark | RHAPSIDO |
| Filing Date | Wednesday, October 30, 2024 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, June 17, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 17, 2025 |
| Goods and Services | Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma |
| Translation of Words in Mark | The wording RHAPSIDO has no meaning in a foreign language. |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, October 30, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Novartis AG |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Basel 4002 CH |
| Party Name | Novartis AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Basel 4002 CH |
| Event Date | Event Description |
| Wednesday, April 30, 2025 | ASSIGNED TO EXAMINER |
| Wednesday, October 30, 2024 | NEW APPLICATION ENTERED |
| Friday, April 25, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, May 1, 2025 | NON-FINAL ACTION WRITTEN |
| Thursday, May 1, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, May 1, 2025 | NON-FINAL ACTION E-MAILED |
| Friday, May 9, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, May 9, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, May 14, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, June 11, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, June 17, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, June 17, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Friday, May 9, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |